Enovis Corp. (ENOV)
21.91
-0.89
(-3.90%)
USD |
NYSE |
Feb 12, 16:00
21.91
0.00 (0.00%)
Pre-Market: 20:00
Enovis Cash from Investing (Quarterly) : -56.06M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -9.933M |
| Abbott Laboratories | -- |
| Accuray, Inc. | -- |
| Alphatec Holdings, Inc. | -13.89M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 82.58M |
| Cash from Financing (Quarterly) | -36.91M |
| Free Cash Flow | 22.76M |
| Free Cash Flow Per Share (Quarterly) | 0.5088 |
| Free Cash Flow to Equity (Quarterly) | 52.60M |
| Free Cash Flow to Firm (Quarterly) | 50.06M |
| Free Cash Flow Yield | 1.83% |